Pain Mechanisms and Neuroinflammation in OA
Plenary Session 5
Time: 10:45 AM to 12:15 PM
Description
Moderators: |
Anne-Marie Malfait Kai Fu |
10:45 AM - 11:25 AM |
Neuroinflammation & Pain: Beyond Immune Cells Franziska Denk |
11:25 AM - 11:35 AM |
085: LEVI-04, A NOVEL NEUROTROPHIN-3 INHIBITOR, SUBSTANTIALLY IMPROVES PAIN AND FUNCTION IN PEOPLE WITH KNEE OSTEOARTHRITIS: A RANDOMISED CONTROLLED PHASE II TRIAL. Philip G. Conaghan |
11:35 AM - 11:45 AM |
086: PROTON-SENSING GPR68 REGULATES JOINT ACIDOSIS AND MODULATES INFLAMMATION AND CATABOLISM IN OSTEOARTHRITIS Colette Hyde |
11:45 AM - 11:55 AM |
087: MAPPING THE SYNOVIAL INNERVATION OF THE HUMAN KNEE JOINT Alia Obeidat |
11:55 AM - 12:05 PM |
088: THE CD13/B1R AXIS MEDIATES SYNOVITIS IN PTOA Easton Farrell |
12:05 AM - 12:07 PM |
089: ASSOCIATION OF CENTRAL PAIN SENSITIZATION WITH PREFRONTAL CORTEX ACTIVATION DURING SINGLE- AND DUAL-TASK WALKING IN KNEE OSTEOARTHRITIS Soyoung Lee |
12:07 PM - 12:09 PM |
090: THE RELATIONS OF ANALGESIC ANTIDEPRESSANTS USE TO TOTAL JOINT ARTHROPLASTY AMONG OSTEOARTHRITIS PATIENTS COMPARED TO SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN A LARGE PROSPECTIVE COHORT Zhiqiang Wang |
12:09 PM - 12:11 PM |
091: COGNITIVE BIAS AND HEURISTICS ARE ASSOCIATED WITH IMPROVEMENT IN KNEE PAIN IN PATIENTS WITH KNEE OSTEOARTHRITIS TREATED WITH OPEN LABEL PLACEBO Tommy Kok Kok Annfeldt |
12:11 PM - 12:13 PM |
092: PHASE I/II CLINICAL TRIAL OF ALLOCETRATM CELL THERAPY FOR KNEE OSTEOARTHRITIS: INITIAL EVIDENCE OF RESPONSE TO INFLAMMATION MODULATION Einat Galamidi |
12:13 PM - 12:15 PM | Q & A |